10x genomics files two new lawsuits requesting preliminary injunctions against nanostring's cosmx products

Also files new suit against vizgen's merscope products for patent infringement pleasanton, calif. , june 1, 2023 /prnewswire/ -- 10x genomics, inc. (nasdaq: txg), a leader in single cell and spatial biology, today announced that it filed new patent litigation against nanostring technologies, inc. (nasdaq: nstg) and vizgen, inc. in the european unified patent court.
NSTG Ratings Summary
NSTG Quant Ranking